[Comprehensive quality indicators for measuring hospital antibiotic use]

There is no fulltext present in this item.

Title:	[Comprehensive quality indicators for measuring hospital antibiotic use]
Author(s):	Bosch, C.M.A. van den; Hulscher, M.E.J.L. ; Wille, J.; Natsch, S.S. ; Benthem, B.H. van; Prins, J.M.; Geerlings, S.E.
Publication year:	2011
Source:	Nederlands Tijdschrift voor Geneeskunde, vol. 155, iss. 33, (2011), pp. A3502
ISSN:	0028-2162
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : http://hdl.handle.net/2066/97534
Display more details
Subject:	N4i 2: Invasive mycoses and compromised host N4i 3: Poverty-related infectious diseases NCEBP 13: Infectious diseases and international health NCEBP 4: Quality of hospital and integrated care NCEBP 7: Effective primary care and public health N4i 1: Pathogenesis and modulation of inflammation NCEBP 7: Effective primary care and public health N4i 1: Pathogenesis and modulation of inflammation
Organization:	IQ Healthcare Primary and Community Care Clinical Pharmacy
Journal title:	Nederlands Tijdschrift voor Geneeskunde
Volume:	vol. 155
Issue:	iss. 33
Page start:	p. A3502
Page end:	p. A3502
Abstract:	As in other countries, the growing resistance to antimicrobial drugs is also taking place in the Netherlands; the primary cause being the total consumption of antibiotics. Given the steady decline in the discovery of new antimicrobials, better use of agents currently available is warranted. Guidelines describing appropriate antimicrobial therapy play an important role; however, such guidelines are not optimally used in daily practice. Quality indicators can be used to assess the quality of antibiotic treatment and evaluate the impact of interventions aimed at improving care. Quality indicators used for evaluating treatment of infections of the respiratory and urinary tracts are developed previously. A comprehensive set of indicators that could be used to assess the quality of hospital antibiotic use for all bacterial infections has not yet been developed. A new project has recently been started in the Netherlands called 'The development of Reliable generic quality Indicators for the optimalisation of ANTibiotic use in the hospital' (RIANT study) for developing such a set of comprehensive indicators.